MedPath

广西铭磊维生制药有限公司

Ownership
-
Established
2018-02-11
Employees
-
Market Cap
-
Website
http://www.gxmlws.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

丹参软胶囊

Approval Number
国药准字Z20090265
Approval Date
Jan 31, 2024
NMPA

Anisodamine Hydrobromide Injection

Product Name
氢溴酸山莨菪碱注射液
Approval Number
国药准字H22020425
Approval Date
Nov 22, 2023
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20223695
Approval Date
Sep 30, 2022
NMPA

Levocarnitine for Injection

Product Name
可尼尤
Approval Number
国药准字H20051070
Approval Date
Mar 9, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.